ANI PHARMACEUTICALS INC

ANIP

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001674236-26-000008
Filing date: Mar 5, 2026
Earliest execution date: Mar 5, 2026
Reporting Owners: CAREY STEPHEN P. (CFO)

Summary

Type

Sell

Net shares

-7,312

% of shares

-3.79%

Amount (USD)

$552,031

Insider confidence score

20.0 out of 100

Negative

  • Large discretionary sell (≥1% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-05

Code

M

Net shares

+3,312.0

Price per Share

$49.51

Amount (USD)

$163,977.12

Acquired/Disposed

Acquired

Shares Owned Before

189,543.0

Shares Owned After

192,855.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-3,312.0

Price per Share

$75.42

Amount (USD)

$249,791.04

Acquired/Disposed

Disposed

Shares Owned Before

192,855.0

Shares Owned After

189,543.0

Transaction 3

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-4,000.0

Price per Share

$75.56

Amount (USD)

$302,240.00

Acquired/Disposed

Disposed

Shares Owned Before

189,543.0

Shares Owned After

185,543.0

Derivative Transactions

Transaction 1

Security

Stock Option (right to buy)

Action

Exercise

Date

2026-03-05

Code

M

Net shares

-3,312.0

Price per Share

$49.51

Amount (USD)

$163,977.12

Acquired/Disposed

Disposed

Shares Owned Before

13,250.0

Shares Owned After

9,938.0

Filing's footnotes

1. The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price.

2. 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.